Macrogenics (MGNX) Times Interest Earned (2023 - 2026)
Macrogenics (MGNX) posted quarterly Times Interest Earned of -$6.11 for Q1 2026, up 98.69% year-over-year from -$3.08 in Q1 2025, and down 115.92% quarter-over-quarter from -$2.83 in Q4 2025.
Analysis
Macrogenics (MGNX) Times Interest Earned (2023 - 2026) Analysis & Trends
Macrogenics (MGNX) has reported Times Interest Earned for 15 consecutive years, with -$6.11 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 98.69% year-over-year to -$6.11; the TTM figure through Mar 2026 stood at -$11.64 (up 99.15% YoY), while the FY2025 annual figure was -$8.56, down 3007.03% from the prior year.
- Times Interest Earned declined to -$6.11 in Q1 2026 per MGNX's latest filing, from -$2.83 in the prior quarter.
- Across five years, Times Interest Earned topped out at $2201.5 in Q4 2024 and bottomed at -$9696.8 in Q2 2024.
- Historically, Times Interest Earned has averaged -$737.65 across 5 years, with a median of -$6.11 in 2026.
- Annual changes were most pronounced in 2024 — Times Interest Earned slumped 45039.17% — and 2025, when it jumped 99.53%.
- Macrogenics' Times Interest Earned stood at -$73.71 in 2022, then soared by 70.86% to -$21.48 in 2023, then soared by 10348.27% to $2201.5 in 2024, then tumbled by 100.13% to -$2.83 in 2025, then slumped by 115.92% to -$6.11 in 2026.
- Business Quant data shows MGNX's Times Interest Earned at -$6.11 in Q1 2026, -$2.83 in Q4 2025, and $5.58 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Macrogenics | 284.90 Mn | 171.00 Mn | - | -3.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.15 |
| Mar 31, 2026 | -6.84 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | 5.58 |
| Jun 30, 2025 | -53.90 |
| Mar 31, 2025 | -468.40 |
| Dec 31, 2024 | 2,201.54 |
| Jun 30, 2024 | -9,696.83 |
| Mar 31, 2024 | -47.44 |
| Jun 30, 2023 | -58.09 |
| Mar 31, 2023 | -58.58 |